Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Randviken Fastigheter AB (publ) in connection with its change of company object and re-listing on Nordic SME
Mandate

Vinge has advised Randviken Fastigheter AB (publ) in connection with its change of company object and re-listing on Nordic SME

September 10, 2021 Banking and Finance Capital Markets and Public M&A Real Estate and Construction

Vinge advises Randviken Fastigheter AB (publ) (”Randviken”) in connection with its change of company object and re-listing on Nordic SME (Nordic Growth Market). The Company Description was made public on 31 August 2021. The change of the company object was due to an indirect acquisition of 35 properties amounting to a total value of SEK 2,778 million.

Randviken is a real estate company with the aim to acquire, manage and refine properties in different segments and geographical locations. In addition to Randviken’s primary focus on stable and long-term cash flows from rented premises, the company’s ambition is to actively engage with intelligent technology to achieve more sustainable and energy efficient properties.

Randviken is listed on Nordic SME (Nordic Growth Market).

Vinges team included David Andersson, Julia Hirschberg and Olivia Belding (Capital Markets and Public M&A), Niclas Winnberg, Kristoffer Larson, Frida Ställborn and Ulf Pyk (Real Estate), as well as Fabian Ekeblad, Paulina Malmberg and Elin Samara (Banking and Finance).

 

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

 Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026